Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL600350 | 1.00 | HCRTR2 (0.44) | HCRTR2HCRTR1 | |
| SCHEMBL600760 | 0.91 | HCRTR2 (0.48) | HCRTR2HCRTR1 | |
| SCHEMBL601067 | 0.90 | HCRTR2 (0.45) | HCRTR2HCRTR1 | |
| SCHEMBL601712 | 0.87 | HCRTR2 (0.46) | HCRTR2HCRTR1 | |
| SCHEMBL599412 | 0.83 | HCRTR2 (0.53) | HCRTR2HCRTR1 | |
| SCHEMBL599312 | 0.83 | HCRTR2 (0.64) | HCRTR2HCRTR1 | |
| SCHEMBL599241 | 0.83 | HCRTR1 (0.65) | HCRTR2HCRTR1 | |
| SCHEMBL601121 | 0.83 | HCRTR1 (0.44) | HCRTR2HCRTR1 | |
| SCHEMBL600595 | 0.83 | HCRTR1 (0.40) | HCRTR2HCRTR1 | |
| SCHEMBL600589 | 0.82 | PROKR1 (0.44) | HCRTR2HCRTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |